Literature DB >> 16873708

Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis.

Hugh S Markus1, Robyn Labrum, Steve Bevan, Markus Reindl, Georg Egger, Christian J Wiedermann, Qingbo Xu, Stefan Kiechl, Johann Willeit.   

Abstract

BACKGROUND AND
PURPOSE: If chronic inflammation plays a causal role in atherogenesis, individuals with proinflammatory gene variants would be expected to develop more atherosclerosis. We recently found a synergistic association between 3 functional proinflammatory gene polymorphisms/haplotypes and smoking on carotid intima-media thickness (IMT). We replicated this finding in a second large population and extended the analysis by inclusion of other inflammatory conditions (chronic infection and obesity/abnormal glucose tolerance).
METHODS: Common carotid and femoral artery IMT was determined in the Bruneck Study population (n=810). Proinflammatory variants were determined in 3 genes (IL-6 [-174C, -572G, -597A haplotype], IL-1-receptor antagonist [VNTR *2], and endotoxin receptor CD-14 [-159C]).
RESULTS: There was a significant relationship between gene-variant score and carotid IMT: age- and sex-adjusted mean IMT in subjects with 0, 1, and >or=2 gene variants was 936, 987 and 1047 microm, respectively (P=0.001), and synergistic effects of gene-variant score and smoking on IMT measurements (P=0.040). Analogous findings were obtained for obesity/abnormal glucose tolerance and chronic infection. Interactive effects of gene-variant score and a risk factor score composed of the acquired inflammatory conditions were highly significant (P<0.001 each). Results were similar for femoral artery IMT.
CONCLUSIONS: These results provide support for a causal role of inflammation in carotid atherosclerosis, and emphasize the importance of gene-gene and gene-environment interactions in this pathogenic pathway. This may help to explain the substantial variability of disease expression in subjects with proinflammatory risk factors such as smoking, diabetes and chronic infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873708     DOI: 10.1161/01.STR.0000236637.72124.3f

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  15 in total

1.  Genetics studies in ischaemic stroke.

Authors:  Hugh S Markus
Journal:  Transl Stroke Res       Date:  2010-08-31       Impact factor: 6.829

2.  Association Between TRAF6 Gene Polymorphisms and Susceptibility of Ischemic Stroke in Southern Chinese Han Population.

Authors:  Li Su; Ziwen Chen; Yan Yan; Baoyun Liang; Juanjuan Xie; Qing Chen; Jinjing Tan; Lian Gu
Journal:  J Mol Neurosci       Date:  2015-05-22       Impact factor: 3.444

3.  Association between PPARs Gene Functional Polymorphisms and Ischemic Stroke in Chinese Uyghur Population.

Authors:  Y Tong; L Cai; Z Wang; Y Zhang; X Guan; F Zhan; J Liu; Q Lu
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

4.  Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.

Authors:  Nibrass Taher Abdali; Awny H Yaseen; Eman Said; Tarek M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-18       Impact factor: 3.000

Review 5.  Common infections and the risk of stroke.

Authors:  Armin J Grau; Christian Urbanek; Frederick Palm
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

6.  The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus.

Authors:  L V Scalzi; S Bhatt; R C Gilkeson; M L Shaffer
Journal:  Lupus       Date:  2009-10-27       Impact factor: 2.911

7.  Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Miina K Ohman; Yuechun Shen; Chinyere I Obimba; Andrew P Wright; Mark Warnock; Daniel A Lawrence; Daniel T Eitzman
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

8.  Role of TLR4 (C1196T) and CD14 (C-260T) Polymorphisms in Development of Ischemic Stroke, Its Subtypes and Hemorrhagic Stroke.

Authors:  Satrupa Das; Subhash Kaul; Akka Jyothy; Anjana Munshi
Journal:  J Mol Neurosci       Date:  2017-09-30       Impact factor: 3.444

Review 9.  Molecular genetics of atherosclerosis.

Authors:  Himadri Roy; Shalini Bhardwaj; Seppo Yla-Herttuala
Journal:  Hum Genet       Date:  2009-03-20       Impact factor: 4.132

10.  Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.

Authors:  Peter Willeit; Simon G Thompson; Stefan Agewall; Göran Bergström; Horst Bickel; Alberico L Catapano; Kuo-Liong Chien; Eric de Groot; Jean-Philippe Empana; Thorleif Etgen; Oscar H Franco; Bernhard Iglseder; Stein H Johnsen; Maryam Kavousi; Lars Lind; Jing Liu; Ellisiv B Mathiesen; Giuseppe D Norata; Michael H Olsen; Aikaterini Papagianni; Holger Poppert; Jackie F Price; Ralph L Sacco; David N Yanez; Dong Zhao; Ulf Schminke; Alpaslan Bülbül; Joseph F Polak; Matthias Sitzer; Albert Hofman; Liliana Grigore; Marcus Dörr; Ta-Chen Su; Pierre Ducimetière; Wuxiang Xie; Kimmo Ronkainen; Stefan Kiechl; Tatjana Rundek; Christine Robertson; Björn Fagerberg; Lena Bokemark; Helmuth Steinmetz; M Arfan Ikram; Henry Völzke; Hung-Ju Lin; Matthieu Plichart; Tomi-Pekka Tuomainen; Moise Desvarieux; Stela McLachlan; Caroline Schmidt; Jussi Kauhanen; Johann Willeit; Matthias W Lorenz; Dirk Sander
Journal:  Eur J Prev Cardiol       Date:  2014-11-21       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.